Inventor
MAMMEN MATHAI
US104 patents
⚠️ This page may combine multiple inventors who share the name “MAMMEN MATHAI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE INC
40 patentsUS7288657B2Oct 30, 2007
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC71 citations99
US6693202B1Feb 17, 2004
Muscarinic receptor antagonists
THERAVANCE INC253 citations99
US7345060B2Mar 18, 2008
Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
THERAVANCE INC63 citations98
US7265133B2Sep 4, 2007
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC65 citations98
US7141671B2Nov 28, 2006
Biphenyl derivatives
THERAVANCE INC145 citations98
US6656694B2Dec 2, 2003
Method for identifying a ligand for a biological substrate
THERAVANCE INC88 citations98
US6635764B2Oct 21, 2003
Therapeutic ureas
THERAVANCE INC149 citations98
US8053448B2Nov 8, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC24 citations96
US8034946B2Oct 11, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC28 citations96
US8017783B2Sep 13, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC17 citations96
US7910608B2Mar 22, 2011
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC32 citations96
US7803812B2Sep 28, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC19 citations96
US7585879B2Sep 8, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC35 citations96
US7560469B2Jul 14, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC37 citations96
US7550595B2Jun 23, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC37 citations96
US7524959B2Apr 28, 2009
Biphenyl derivatives
THERAVANCE INC36 citations96
US7524965B2Apr 28, 2009
Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
THERAVANCE INC44 citations96
US7521041B2Apr 21, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC27 citations96
US7521561B2Apr 21, 2009
Biphenyl derivatives
THERAVANCE INC36 citations96
US7514558B2Apr 7, 2009
Biphenyl derivatives
THERAVANCE INC32 citations96
US7507751B2Mar 24, 2009
Biphenyl derivatives
THERAVANCE INC33 citations96
US7491736B2Feb 17, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC29 citations96
US7456199B2Nov 25, 2008
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC49 citations96
US7355046B2Apr 8, 2008
Biphenyl derivatives
THERAVANCE INC42 citations96
US7345175B2Mar 18, 2008
Biphenyl derivatives
THERAVANCE INC49 citations96
US7262205B2Aug 28, 2007
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC50 citations96
US7829583B2Nov 9, 2010
Biphenyl derivatives
THERAVANCE INC15 citations93
US7816532B2Oct 19, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC16 citations93
US7687519B2Mar 30, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC25 citations93
US7687521B2Mar 30, 2010
Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
THERAVANCE INC23 citations93
US7683173B2Mar 23, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC23 citations93
US7659403B2Feb 9, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC25 citations93
US7642355B2Jan 5, 2010
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC32 citations93
US7632847B2Dec 15, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC24 citations93
US7629336B2Dec 8, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC29 citations93
US7569588B2Aug 4, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC34 citations93
US7524962B2Apr 28, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC37 citations93
US7501442B2Mar 10, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC40 citations93
US7479562B2Jan 20, 2009
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE INC39 citations93
US7317102B2Jan 8, 2008
Diarylmethyl and related compounds
THERAVANCE INC17 citations93
MAMMEN MATHAI
5 patentsUS8273894B2Sep 25, 2012
Biphenyl compounds useful as muscarinic receptor antagonists
MAMMEN MATHAI15 citations96
US8173815B2May 8, 2012
Biphenyl compounds useful as muscarinic receptor antagonists
MAMMEN MATHAI15 citations96
US9045443B2Jun 2, 2015
Nitric oxide donor neprilysin inhibitors
MAMMEN MATHAI53 citations94
US9452161B2Sep 27, 2016
Biphenyl compounds useful as muscarinic receptor antagonists
MAMMEN MATHAI11 citations92
US9283183B2Mar 15, 2016
Biphenyl compounds useful as muscarinic receptor antagonists
MAMMEN MATHAI12 citations92
THERAVANCE BIOPHARMA R&D IP LLC
5 patentsUS11247969B2Feb 15, 2022
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE BIOPHARMA R&D IP LLC6 citations94
US10570092B2Feb 25, 2020
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE BIOPHARMA R&D IP LLC8 citations93
US10343995B2Jul 9, 2019
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE BIOPHARMA R&D IP LLC9 citations93
US10106503B2Oct 23, 2018
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE BIOPHARMA R&D IP LLC9 citations93
US9926272B2Mar 27, 2018
Biphenyl compounds useful as muscarinic receptor antagonists
THERAVANCE BIOPHARMA R&D IP LLC9 citations93
Showing the top 50 of 104 patents by PatentIndex Score.